Applications Published 7 November 2001
Published: 1-Jul-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid
Baylor University Medical Centre 1150579*
Use of nanoscale chitosanes and/or chitosane derivatives
Cognis Deutschland 1150655*
Spray containing ubiquinone QN
MSE Pharmazeuticka 1150657*
Method for controlling liposome size
Alza Corp 1150658*
Pharmaceutical effervescent formulation containing metamizol
Hexal 1150660*
Topical sprays comprising a film-forming compsn
Cipla 1150661*
Laminates containing an active substance for transdermal systems
Jenpharm 1150662*
Method fro producing film-type dosage forms
LTS Lohmann Therapie-Systeme 1150663*
Novel use of orexin receptor antagonists
SmithKline Beecham 1150664*
Use of statins for treating viral infections
Hollis-Eden Pharmaceuticals 1150665*
Stimulating neurotrophil function to treat inflammatory bowel disease
Washington University 1150666*
Use of a cyclohexanone long-chain alcohol for treating neurodegenerative diseases
Meiji Dairies Corp 1150667*
New utilisation of propionic acid in medicine
Da Silva, Benedito C¢ndido 1150668*
L-arginine based formulations for treating diseases and methods of using same
Nitrosystems 1150669*
Alkylating agents for treatment of cellular proliferation
Quanam Medical Corp 1150670*
Use of pyrethroid compounds to promote hair growth
The General Hospital Corp 1150671*
Method to aid smoking cessation
Knoll Pharmaceutical 1150672*
Mono-acyloyl aralkyl neuromuscular relaxants
Newlaxant 1150673*
Use of pyrrolidine derivatives for the manufacture of a pharmaceutical compsn for the treatment or prophylaxis of obesity or appetite regulation
Novo Nordisk 1150674*
A transdermal compsn of an antivomiting agent and a preparation containing the same
Samyang Corp 1150675*
Acyl derivatives of 4-demethylpenclomedine, use thereof and preparations thereof
Southern Research Institute 1150676*
New pharmaceutical formulation
AstraZeneca 1150677*
Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy
AstraZeneca 1150678*
Use of cholesterol-lowering agent
AstraZeneca 1150679*
Use of moxonidine for postmyocardial infarction treatment
Solvay Pharmaceutical 1150680*
Pharmaceutical compsn containing desoxypeganine for the treatment of nicotine dependence
LTS Lohmann Therapie-Systeme 1150681*
Ubiquinone QN for the treatments of pains
MSE Pharmazeutika 1150682*
Utilisation of dienogest in high doses
Jenapharm 1150683*
Anti-resporptive bone cements and allogenic, autografic and xenografic bone grafts
Sloan-Kettering Institute for Cancer Research 1150684*
Phosphocholine surfactants and their use
SuperGen 1150685*
Directly compressible matrix for controlled release of single daily doses of clarithromycin
Lek, Tovarna Farmacevtskih in Kemicnih Izdelkov 1150686*
Methods for antitumour therapy
Cellpath 1150687*
Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens
Yeda Research and Development 1150688*
Chemical compounds
Norsk Hydro 1150689*
Novel antisense inhibition of RAD51
Pangene 1150691*
Means for regulating hematopoietic differentiation
Institut National de la Sante et de la Recherche Medicale 1150692*
Immunogenic compsns for use as vaccines
Institut de Recherche pour la Developpement 1150693*
Cell compns containing macrophages, presenting anti-infectious and hematopoietic properties, and a process for preparing the same
IDM Immuno-Designed Molecules 1150694*
Herbal supplement for increased muscular strength and endurance for athletes
Djananov, Atanas Russinov 1150695*
Treatment of tumours with genetically engineered herpes virus
Arch Development Corp/The UAB Research Foundation 1150696*
High molecular weight extracts of Convulvulus arvensis (field bindweed)
The Centre for the Improvement of Human Functioning International 1150697*
Use of vascular endothelial growth factor in the treatment of erectile dysfunction
The Trustees of Columbia University in the City of New York 1150698*
Treatment of bladder and gastrointestinal mastocytosis
Lezdey, John; Lezdey, Darren 1150699*
Antiangiogenic drugs
National Institute of Immunology; Dabur Research Foundation 1150700*
Homing pro-apoptotic conjugates and methods of using same
The Burnham Institute 1150701*
Utilisation of orosomucoid in order to produce a pharmaceutical preparation
Baxter international 1150702*
Chaperonin 10 and beta-interferon therapy of multiple sclerosis
The University of Queensland 1150703*
New use of melagatran
AstraZeneca 1150704*
Protection of cells in connection with treatment with chemical agents
Eberhard-Karls-UniversitaetTuebingen 1150705*
Use of an enterobacterium protein OMPA associated with an antigen for generating an antiviral, antiparasitic or antitumoural cytotoxic response
Pierre Fabre Medicament 1150706*
Use of an OMPA enterobacterium proetin associated with the elagigil tv peptide for treating melanomas
Pierre Fabre Medicament 1150707*
Polynucleotide encoding multimers of antiogenic peptides in order to enhance presentation of the antigenic peptide by MHC molecules
Genzyme 1150708*
Anti-microbial agents, diagnostic reagents, and vaccines based on apicomplexan parasite components
McLeod, Rima; Roberts, Craig; Roberts, Fiona; Johnson, Jennifer; Kiristis, Michael; Ferguson, David; Lyons, Russell; Mui, Ernest; Mack, Doug; Samuel, Benjamin; Gorniki, Piotri; Zuther, Ellen 1150709*
Immunogenic complexes and methods relating thereto
CSL 1150710*
Compsns and methods for treating and preventing pathogenic bacterial infection based on the essential role of DNA methylation in bacterial virulence
The Regents of the University of California 1150711*
Human papilloma virus vaccine formulations
Merck 1150712*
Vaccine formulation comprising monoglycerides or fatty acids as adjuvant
Eurocine 1150713*
Pharmaceutical compsns containing nicotine or a ligand of nicotine receptors and a monoamine oxydase inhibitor and their use for treating tobacco withdrawal symptoms
Sanofi-Synthelabo 1150715*
Pharmaceutical compsn of hydrophobically modified hedgehog proteins and their use
Curis 1150716*
Sustained release salts of pharmaceutically active peptides and their production
Zentaris 1150717*
Conjugates of lipids and antimicrobial or antineoplastic drugs
Oregon Health Sciences University 1150718*
